3 things to know about teplizumab, the new diabetes drug
Yale endocrinologist Kevan Herold discusses an important new treatment that delays the onset of type 1 diabetes.
Source: Yale Science and Health News - Category: Universities & Medical Training Source Type: news
More News: Diabetes | Diabetes Type 1 | Endocrinology | Health | Science | Universities & Medical Training | Yale